Health Condition 1: null- Health condition â??Breast cancer patients negative for triple receptors, Problem studied â??Early metastasis and rapid growth of cancer due to inability to respond to hormonal therapy. Health Condition 2: C50- Malignant neoplasm of breast
Conditions
Interventions
Intervention1: SBD/MKD/ST/AT/JMO/CHEMOTHERAPY/PANCHAKARMA: Study group 1A
Morning â?? Evening â?? Suvarnabhasmadi Yoga â?? 395 mg with cowâ??s milk, MauktikyuktaKamdudha â?? 500 mg, ShatavariVati â??
Sponsors
Dr Vasanti Godse
Dr S P Sardeshmukh
Dr Shubhada Chiplunkar
Dr Sudha Gangal
Dr Tushar Patil
Dr Vineeta VDeshmukh
Eligibility
Inclusion criteria
Inclusion criteria: Immunohistochemically proved triple negative breast cancer patients of stages I to III, in the age group between 25 and 75 will be included in the study
Exclusion criteria
Exclusion criteria: Patients with distant metastasis at diagnosis (Stage IV) will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For assessment of recurrence or metastasis, clinical examination, mammography, PET CT, CT scan (Abdomen and pelvis), 2 D echo, and other imaging techniquesTimepoint: Day 0 (Before Starting Ayurvedic Medicines), After 6 months of Ayurvedic medicines, After 1 year of Ayurvedic medicines, After 1.5 years of Ayurvedic medicines, After 2 years of Ayurvedic medicines, After 2.5 years of Ayurvedic medicines, After 3 years of Ayurvedic medicines. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Kidney Function TestTimepoint: Day 0 (Before Starting Ayurvedic Medicines), After 6 months of Ayurvedic medicines, After 1 year of Ayurvedic medicines, After 2 years of Ayurvedic medicines, After 3 years of Ayurvedic medicines;Changes in Liver Function TestTimepoint: Day 0 (Before Starting Ayurvedic Medicines), After 6 months of Ayurvedic medicines, After 1 year of Ayurvedic medicines, After 2 years of Ayurvedic medicines, After 3 years of Ayurvedic medicines;Changes in Oxidative stress by Catalase, SOD, GST and GSTP1 Hypermethylation Timepoint: Day 0 (Before Starting Ayurvedic Medicines), After 6 months of Ayurvedic medicines, After 1 year of Ayurvedic medicines, After 2 years of Ayurvedic medicines, After 3 years of Ayurvedic medicines;Blood SugarTimepoint: Day 0 (Before Starting Ayurvedic treatment);Changes in C Reactive ProtienTimepoint: Day 0 (Before Starting Ayurvedic Medicines), After 6 months of Ayurvedic medicines, After 1 year of Ayurvedic medicines, After 2 years of Ayurvedic medicines, After 3 years of Ayurvedic medicines;Changes in HaemogramTimepoint: Day 0 (Before Starting Ayurvedic Medicines), After 6 months of Ayurvedic medicines, After 1 year of Ayurvedic medicines, After 2 years of Ayurvedic medicines, After 3 years of Ayurvedic medicines;Changes in Immune parameters (cytokines)like IL 1, IL- 6, IL-8, IL -10, IFN Gamma, TNF Alpha Timepoint: Day 0 (Before Starting Ayurvedic Medicines), After 6 months of Ayurvedic medicines, After 1 year of Ayurvedic medicines, After 2 years of Ayurvedic medicines, After 3 years of Ayurvedic medicines;Changes in Karnofsky score â?? For performance statusTimepoint: Day 0 (Before Starting Ayurvedic Medicines), After 6 months of Ayurvedic medicines, After 1 year of Ayurvedic medicines, After 2 years of Ayurvedic medicines, After 3 years of Ayurvedic medicines;Changes in Quality of Life Questionnaires (QLQ C30 and BR23) of EORTC for Quality of LifeTimepoint: Day 0 (Before Starting Ayurvedic Medicines), Afte | — |
Countries
India
Contacts
Public ContactDr Anita Shingate
Integrated Cancer Treatment and Research Centre
Outcome results
None listed